Royalty Pharma plc
RPRX
Clasificación en acciones
#879
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Precio por acción
$61.57
Capitalización bursátil
$27.42B
Cambio (1 día)
2.16%
Cambio (1 año)
68.09%
País
US
Comercio Royalty Pharma plc (RPRX)
Categoría
Healthcare
Historial de rendimiento por dividendo de Royalty Pharma plc (RPRX)
Rendimiento por dividendo (TTM) de Royalty Pharma plc (símbolo bursátil: RPRX) al 2023-12-31: 2.85%
Rendimiento promedio por dividendo de los últimos 5 años: 2.37%
Rendimiento promedio por dividendo de los últimos 5 años: 2.37%
Historial de rendimiento por dividendo de Royalty Pharma plc (RPRX) desde 2015 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
| Año | Rendimiento por dividendo | Cambiar |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
Rendimientos por dividendo (TTM) de empresas similares o competidoras
| Empresa | Rendimiento por dividendo | País |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 2.29% |
HK
|
